ADORA2A and Parkinson disease: Istradefylline (trade name NourianzTM) is an adenosine A2A receptor antagonist approved by the U.S. Food and Drug Administration (FDA) as an add-on treatment to levodopa/carbidopa for adult Parkinson’s disease patients experiencing “off” episodes [37].